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Abstract
Background: Molecular detection of herpesviruses DNA is considered as the reference standard
assay for diagnosis of central nervous system infections. In this study nested PCR and real time PCR
techniques for detection of Herpes simplex virus type 1 (HSV-1), Cytomegalovirus (CMV) and
Epstein-Barr virus (EBV) in cerebrospinal fluid of HIV patients were compared.
Methods: Forty-six, 85 and 145 samples previously resulted positive for HSV-1, CMV and EBV by
nested PCR and 150 randomly chosen negative samples among 1181 collected in the period 1996–
2003 were retrospectively reassessed in duplicate by real time PCR and nested PCR.
Results: Samples giving positive results for CMV, HSV-1 and EBV with nested PCR were positive
also with real time PCR. One of the negative samples resulted positive for HSV and one for EBV.
Real time PCR showed comparable sensitivity and specificity vs nested PCR.
Conclusion: Real time PCR proved to be a suitable method for diagnosis of herpesvirus infections
in CNS, showing comparable sensitivity and being less time consuming than nested PCR.
Background
Opportunistic infections as well as tumors and vascular
and metabolic disorders are common in HIV-infected
patients [1-3]. Generally, opportunistic viral infections are
caused by a broad spectrum of different species with sim-
ilar clinical patterns, especially those affecting the central
nervous system (CNS), where differential diagnosis
requires simultaneous screening of a wide range of differ-
ent viruses [4,5]. Moreover, immunodeficiency induced
by HIV infection favours reactivation of herpesviruses
which could cause important diseases by themselves [6].
Although the rate of CNS complications is relatively low,
if compared with the high prevalence of herpesviruses in
the population, these viruses represent the most impor-
tant pathogens associated with viral encephalitis and
meningitis [7,8], being cytomegalovirus (CMV) the most
frequently identified virus in HIV-positive patients, fol-
lowed by Epstein-Barr virus (EBV) and Herpes simplex
virus type 1 (HSV-1) [9]. CMV, that is often responsible of
asymptomatic infections in immunocompetent host, is
able to cause serious manifestations such as retinitis,
pneumonia and encephalitis in presence of an alteration
of immunoresponse, while the recovery of Epstein-Barr
Published: 30 November 2004
BMC Infectious Diseases 2004, 4:55 doi:10.1186/1471-2334-4-55
Received: 08 July 2004
Accepted: 30 November 2004
This article is available from: http://www.biomedcentral.com/1471-2334/4/55
© 2004 Drago et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.BMC Infectious Diseases 2004, 4:55 http://www.biomedcentral.com/1471-2334/4/55
Page 2 of 5
(page number not for citation purposes)
virus (EBV) in cerebrospinal fluid (CSF) seems to be a
prognostic sign for the development of cerebral tumors in
patients with AIDS [10,11]. HSV-1 is the most commonly
detected virus in diagnostic laboratory, being cause of a
variety of clinical symptoms in different anatomical sites
such as skin, lips, oral cavity and, especially in immuno-
compromised patients, CNS [12].
One-step or nested polymerase chain reaction (PCR) has
rapidly replaced immunological assays based on virus
specific Ig antibodies in CSF for laboratory diagnosis of
Herpesvirus infections, even if serological methods are
considered an additional tool for defining clinical
diagnosis.
Although nested PCR is considered the method of choice
in terms of specificity [9,13,14], some additional aspects
should be considered.
In the last years, introduction of real time PCR has mark-
edly increased the ease and the speed in the virology lab-
oratory due to the relevant technology that permits rapid
temperature cycling within a close system. Considering
the importance of relationship between viral load in CSF
and severity and outcome of disease, an additional advan-
tage of Real Time PCR is the capability to perform simul-
taneous qualitative and quantitative analysis.
Here is reported our experience gained in the diagnosis of
herpesvirus infections of the CNS in HIV patients by
means of nested PCR and Real Time PCR, which has been
recently applied in our laboratory.
Methods
CSF samples collection
A total of 1181 CSF samples collected in the period 1996
– 2003 from HIV patients attending at Luigi Sacco Teach-
ing Hospital of Milan (Italy) affected by acute encephalitis
or meningitis or encephalopathy or other neurological
syndromes were considered.
Particularly, they consisted of 684, 954 and 933 CSF sam-
ples previously tested for HSV-1, CMV and EBV, respec-
tively, by means of nested PCR. Of these, all the positive
samples and 150 negative samples randomly chosen were
retested by means of nested PCR and real time PCR. Each
sample was re-extracted and run in duplicate.
CSF positive and negative samples were stored at -80°C
until analysis.
Clinical data of patients with positive samples were avail-
able only in the 20% of the total. These patients generally
recorded meningoencephalitis signs such as central motor
or sensory alterations, consciousness loss, seizures defects.
Nucleic acid extraction
Spin-column based QIAamp Mini Kit (Quiagen, Hilden,
Germany) protocol extraction for CSF was used as indi-
cated by the manufacturer.
This procedure allowed for the rapid purification of DNA
from 200 µL of CSF and comprised four successive steps
carried out using QIAamp Spin Columns in a standard
microcentrifuge. Purified DNA was concentrated at a final
volume of 20 µL.
Nested PCR
Nested PCR was carried out in a 50 µl mixture containing
40 µl of first amplification mix (outer primers, buffer,
dNTP)-(Amplimedical SpA-Bioline Division-Italy), 2U/µl
Taq DNA polymerase (Roche Diagnostics-Germany) and
5 µl of purified DNA. Primer pairs selecting for glycoprotein
D gene of HSV-1 [15], for the late protein gp58 of CMV
[16], and for Bam HI-W region of EBV [17] are shown in
Table 1.
Table 1: Nucleotide base sequence of primers used in nested PCR
Virus Region Primer (5'-3')








EBV BamH I – W Outer GAGACCGAAGTGAAGGCCCT
GGTGCCTTCTTAGGAGCTGT
Inner GCCAGAGGTAAGTGGACTTTAAT
GAGGGGACCCTGAGACGGGTBMC Infectious Diseases 2004, 4:55 http://www.biomedcentral.com/1471-2334/4/55
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After an initial 2 min denaturation at 94°C, 35 cycles of
94°C for 30 sec, 55°C for 30 sec and 72°C for 30 sec were
carried out, followed by a 5 min extension at 72°C using
a thermal cycler (Gene Amp PCR System 2400-Applied
Biosystem – Monza – Italy). The reaction mixture for the
second amplification round was the same as for the first
one, except for the "inner" primers used instead of the
"outer" primers. In the second amplification round 44 µl
of amplification mix and 1 µl of the first amplification
round PCR product were used. The thermal cycling was
repeated as for the first amplification round but using 30
cycles after the initial 2 min denaturation. Each amplifica-
tion run contained a negative control, consisting of water
and a positive plasmidial control.
Analysis for the PCR products was performed by means of
4 % agarose gel electrophoresis followed by visualization
with ethidium bromide (0.4 µg/mL) staining and UV illu-
mination to confirm the expected products.
Real Time PCR
For diagnostic real time PCR Taq polymerase RT PCR Kit
(Amplimedical SpA-Bioline Division-Turin Italy) was
used. Target regions for HSV and CMV were the same as in
nested PCR, while EBNA-1 gene was amplified for EBV [9]
as shown in Table 2..
The RT PCR was performed in 25 µl mixture containing 20
µl of amplification mix (buffer, dNTPs, Taq gold polymer-
ase, Rox passive fluorocrome, primers and MGB Eclipse
probe) and 5 µl of purified DNA.
The amplification program included an initial decontam-
ination with uracile N'-glycosilase at 50°C for 2 min,
followed by denaturation at 95°C for 10 min and 45 two
steps of 15 sec at 95°C and 1 min at 60°C.
The RT PCR products were detected by measuring fluores-
cence with passive reference dye in Sequence Detection
System ABI Prism 7000 (Applied Biosystem). Control
threshold (Ct) values were calculated by determining the
point at which the fluorescence exceeded a background
limit of 0.04. Each analytical session comprised also a
negative control (distilled water).
Quantification was carried out by analysing four positive
plasmidial standards at 102, 103, 104 and 105 copies/reac-
tion. The standards were obtained by cloning the target
amplification product in a plasmid, which was trans-
formed and cultured in Escherichia coli. Plasmidic DNA
was purified with a commercial kit (Qiagen) and its con-
centration determined spectrophotometrically. Then,
plasmidic DNA was serially diluted in a stabilizing buffer
to the final desired concentration. Amounts of copies/mL
in each sample were determined by means of a quantifica-
tion software (Amplimedical), by considering an extrac-
tion recovery of 80%.
Results
Nested PCR
Of 954 CSFs previously examined for CMV by means of
nested PCR, 85 samples resulted positive. Among the 684
CSFs tested for HSV-1, 46 samples were found positive,
while, 145 of 933 CSFs tested resulted positive for EBV.
Reassessment of these positives and of 150 negative sam-
ples confirmed results previously obtained with the same
method, with the exception of one HSV-1 positive sample,
which resulted negative when retested, as shown in Table
3.
Table 2: Nucleotide base sequence of primersused for real time PCR
Virus Region Primer (5'-3')
HSV-1 GpD Forward CATACCGGAACGCACCACACAA
Reverse CCATATCGACCACACCGACGA
CMV MIEA Forward AAGCGGCCTCTGATAACCAAGCC
Reverse AGCACCATCCTCCTCTTCCTCTGG
EBV EBNA-1 Forward ATCAGGGCCAAGACATAGAGATG
Reverse CCTTTGCAGCCAATGCAACT
Table 3: Results from nested PCR and real-time PCR
NESTED PCR REAL TIME PCR
POS NEG POS NEG
CMV 85 150 85 150
HSV-1 45 150+1a = 151 45+1b = 46 149+1a = 150
EBV 145 150 145 +1b = 146 149
a: sample resulted positive in previous nested PCR
b: samples resulted negative in nested PCRBMC Infectious Diseases 2004, 4:55 http://www.biomedcentral.com/1471-2334/4/55
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Real Time PCR
Results from real time PCR are reported in Table 3. All the
samples for which nested PCR gave positive results were
confirmed by Real Time-PCR for CMV, HSV-1 and EBV.
Of the 150 samples resulted negative by nested PCR, 148
were negative, while 1 sample resulted positive for HSV
and 1 for EBV. The positive sample giving negative result
when reassessed by nested PCR was negative also by real
time PCR.
Sensitivity and specificity
By considering nested PCR as gold standard [9,13], sensi-
tivity and specificity of real time PCR are described in
Table 4. Comparable sensitivity (100%) and specificity
(99–100 %) were found for real time PCR in respect to
nested PCR.
Discussion
Introduction of PCR into routine diagnostic has rapidly
gained a pivotal role for diagnosis of a wide range of dis-
eases, supplanting, in many cases, other methods, such as
the classical serodiagnosis. This is particularly true for
diagnosis of herpes virus infections in immunocompro-
mised patients, where diminished or suppressed virus-
specific antibody responses do not reflect possible reacti-
vated herpes mediated aethiologies [18].
Real time PCR has represented a further step forward,
since it allows for quantitative detection of target DNA in
a single sample over a large range, remaining possible
qualitative detection. Even if contradictory results have
been found [19-21], quantification of DNA could
represent an important issue to evaluate the severity and
outcome of herpesvirus encephalitis, and it may be also
used to monitor the success of antiviral therapy. This strat-
egy has already been used for monitoring of patients at
risk for CMV infections, when viral load kinetic patterns
are used to identify patients who are more likely to have
recurrence of CMV disease after the initiation of therapy,
as well as to identify patients needing treatment [22-24].
Moreover, in these cases, use of a highly sensitive assay
could be of crucial value.
In the last years several real-time PCR methods have been
developed for detection of herpesviruses in different bio-
logical specimens [25-27]. Real-time PCR has been well
recognized to offer several advantages over nested PCR
other than allowing quantification of viral load: it reduces
the risk of amplicon contamination, being a close-system,
is a safer laboratory protocol by not using ethidium bro-
mide, and it allows a notable reduction of time required
for response.
In the present work, we compared a real time PCR panel
for detection of herpesvirus DNA in CSF with methods
employing nested PCR. Our results indicate an overall
agreement between the two methods, as reported by other
authors [9,27,28]. Differences between the two assays
were observed for HSV-1 and EBV analysis, where one
negative sample was found positive by real time PCR.
Since extraction panels and primers for HSV and CMV
were uniform for the both types of assays, inhibitors
present in the DNA preparations could not explain the
different results obtained for these samples. Moreover,
being nested PCR generally considered as the gold stand-
ard for diagnosis of herpes virus in CSF, we tried to use
similar primers, chemistry and amplification conditions
in order to limit differences for a better comparison of the
performance of the two methods. Thus, discrepancies
could be likely attributed to the different detection of
amplification products, although real time PCR has been
reported to be as sensitive as nested PCR [29]. This sugges-
tion is also supported by the fact that the two patients
with CSF negative for HSV-1 and EBV with nested PCR
showed clinical syndromes compatible with viral
encephalitis and clinically improved with antiviral treat-
ment (data not shown). These data seem to suggest that
real time PCR could be more sensitive than nested PCR.
Since the limit of detection is generally calculated by using
plasmidial DNA, it may be possible that, although molec-
ular sensitivity is reported to be similar for nested PCR
and real-time PCR [27,28], some differences may occur
for biological specimens. The sample classified positive
for HSV-1, which resulted negative when retested with
both methods, was one of the oldest in our collection,
dating 1996, and it might have degraded over the 7 years
storage. From this point of view, development of stand-
ardized quality controls might be very helpful [30].
Conclusions
Data obtained in this study confirms the validity of real-
time PCR method for detection of herpesvirus DNA in
CSF specimens of HIV patients, being sensitive, rapid and
quantitative. Since specific and rapid diagnosis is the
Table 4: Sensitivity and specificity of nested PCR and real-time 
PCR
Real-time PCR
Sensitivity (%) Specificity (%)
CMV 85/85 = 100% 150/150 = 100%
HSV-1 45/45 = 100% 150/151 = 99%
EBV 145/145 = 100% 149/150 = 99%BMC Infectious Diseases 2004, 4:55 http://www.biomedcentral.com/1471-2334/4/55
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main target in the case of CNS infections, real time PCR
could be considered the method of choice, due to its high
specificity, sensitivity and rapidity, once proper quality
controls will be available.
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